48,833
edits
(→Metaplastic breast carcinoma: tweak -- add notes) |
(→Molecular classification of invasive carcinoma: tweak wording) |
||
Line 166: | Line 166: | ||
|} | |} | ||
The above is not applied clinically. [[ | The above is not applied clinically. A panel of [[immunostains]] (ER, PR, HER2, EGFR, CK5/6) can reproduce the molecular groupings.<ref name=pmid19704256>{{Cite journal | last1 = Tang | first1 = P. | last2 = Skinner | first2 = KA. | last3 = Hicks | first3 = DG. | title = Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? | journal = Diagn Mol Pathol | volume = 18 | issue = 3 | pages = 125-32 | month = Sep | year = 2009 | doi = 10.1097/PDM.0b013e31818d107b | PMID = 19704256 }}</ref> | ||
==Subtyping breast cancer== | ==Subtyping breast cancer== |
edits